Major Depressive Disorder
Articles and Guidelines
- Prospective biomarkers of major depressive disorder: a systematic review and meta-analysis [Mol Psychiatry 2020]
- Impact of Major Depressive Disorder on Comorbidities: A Systematic Literature Review [J Clin Psychiatry 2022]
- Genetics and major depressive disorder: clinical implications for disease risk, prognosis and treatment [Int Clin Psychopharmacol 2020]
- Evaluating the Role of Ketamine/Esketamine in the Management of Major Depressive Disorder with Suicide Risk [CNS Drugs 2021]
- Major Depressive Disorder in Older Patients as an Inflammatory Disorder: Implications for the Pharmacological Management of Geriatric Depression [Drugs Aging 2021]
- Folate as adjunct therapy to SSRI/SNRI for major depressive disorder: Systematic review & meta-analysis [Complement Ther Med 2021]
- Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials: individual participant data analysis [BMJ 2022]
- Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder [Cochrane Database Syst Rev 2021]
- Changes in Sertraline Plasma Concentrations Across Pregnancy and Postpartum [Clin Pharmacol Ther 2022]
- Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial [JAMA Psychiatry 2021]
- APA 2019 Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts
- VA/DoD Clinical Practice Guidelines Management of Major Depressive Disorder (MDD) (2022)
- Nonpharmacologic and Pharmacologic Treatments of Adults in the Acute Phase of Major Depressive Disorder: A Living Clinical Guideline From the American College of Physicians (2023)
- Journal of the American Academy of Child and Adolescent Psychiatry (2023)
- American Academy of Pediatrics Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Practice Preparation, Identification, Assessment, and Initial Management (2018)
- NICE Guidelines on Depression in adults: treatment and management (2022)
- NICE Guidelines on Depression in children and young people: identification and management (2019)
- CPIC® Guideline for Serotonin Reuptake Inhibitor Antidepressants and CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A (2023)
- CPIC® Guideline for Tricyclic Antidepressants and CYP2D6 and CYP2C19 (2016)
- Effectiveness of vortioxetine in patients with major depressive disorder comorbid with generalized anxiety disorder: Results of the RECONNECT study [J Psychopharmacol 2022]
- Psychological and pharmacological treatments for generalized anxiety disorder (GAD): a meta-analysis of randomized controlled trials [Cogn Behav Ther 2020]
- Role of Benzodiazepines in Anxiety Disorders [Adv Exp Med Bio 2020]
- Novel pharmacological treatments for generalized anxiety disorder: Pediatric considerations [Depress Anxiety 2020]
- Current and Novel Psychopharmacological Drugs for Anxiety Disorders [Adv Exp Med Biol 2020]
- Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study [Aust N Z J Psychiatry 2020]
- Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options [Front Psychiatry 2020]
- Anxiety Disorders in the Elderly [Adv Exp Med Biol 2020]
- American Family Physician Generalized Anxiety Disorder and Panic Disorder in Adults (2022)
- 2020 NICE Guidelines Generalised anxiety disorder and panic disorder in adults: management
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the pharmacological treatment of anxiety disorders, obsessive – compulsive disorder and posttraumatic stress disorder in primary care (2012)
- Schizophrenia in a genomic era: a review from the pathogenesis, genetic and environmental etiology to diagnosis and treatment insights [Psychiatr Genet 2020]
- Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis [Br J Psychiatry 2022]
- Improving adherence to pharmacological treatment for schizophrenia: a systematic assessment [Expert Opin Pharmacother 2021]
- Antipsychotic treatment in elderly patients on polypharmacy with schizophrenia [Curr Opin Psychiatry 2022]
- Maintenance Treatment With Antipsychotic Drugs in Schizophrenia: A Cochrane Systematic Review and Meta-analysis [Schizophr Bull 2022]
- Paliperidone Extended Release Versus Olanzapine in Treatment-Resistant Schizophrenia: A Randomized, Double-Blind, Multicenter Study [J Clin Psychopharmacol 2022]
- Long-acting antipsychotics in the treatment of schizophrenia: opportunities and challenges [Expert Opin Pharmacother 2023]
- Clinical Recovery and Long-Term Association of Specialized Early Intervention Services vs Treatment as Usual Among Individuals With First-Episode Schizophrenia Spectrum Disorder20-Year Follow-up of the OPUS Trial [JAMA Psychiatry. 2023]
- Association of Long-Acting Injectable Antipsychotics and Oral Antipsychotics With Disease Relapse, Health Care Use, and Adverse Events Among People With Schizophrenia [JAMA Netw Open. 2023]
- Examination of Dosing of Antipsychotic Drugs for Relapse Prevention in Patients With Stable Schizophrenia [JAMA Psychiatry. 2021]
- The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia (2020)
- British Association for Psychopharmacology (BAP) Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology (2020)
- Canadian Psychiatric Association Guidelines for the Pharmacotherapy of Schizophrenia in Adults (2017)
- NICE Guidelines on Psychosis and schizophrenia in adults: prevention and management (2014)
- NICE Guidelines on Psychosis and schizophrenia in children and young people: recognition and management (2016)
- Old Age Bipolar Disorder-Epidemiology, Aetiology and Treatment [Medicina (Kaunas) 2021]
- ADHD and Bipolar Disorder in Adulthood: Clinical and Treatment Implications [Medicina (Kaunas) 2021]
- Treatment of Mixed Features in Bipolar Disorder: an Updated View [Curr Psychiatry Rep 2020]
- Comparison of bipolar disorder type II and major depressive disorder [J Affect Disord 2023]
- Bipolar disorder: Treatment strategies for women of childbearing age [Perspect Psychiatr Care 2021]
- Clinical picture and treatment of bipolar affective disorder in children and adolescents [Psychiatr Pol 2020]
- Psychiatrist and Psychiatric Pharmacists Beliefs and Preferences for Atypical Antipsychotic Treatments in Patients With Schizophrenia and Bipolar Disorders [J Pharm Pract 2021]
- Assessing Outcomes Between Risperidone Microspheres and Paliperidone Palmitate Long-Acting Injectable Antipsychotics Among Veterans [Fed Pract 2021]
- Duration of Adjunctive Antidepressant Maintenance in Bipolar I Depression [N Engl J Med 2023]
- National Institute for Health and Care Excellence (NICE) Bipolar disorder: assessment and management (2020)
- American Psychiatric Association PRACTICE GUIDELINE FOR THE Treatment of Patients With Bipolar Disorder (2002)
- American Academy of Child & Adolescent Psychiatry Practice Parameter for the Assessment and Treatment of Children and Adolescents With Bipolar Disorder (2007)
- British Association for Psychopharmacology Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology (2016)
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder
- Veterans Affairs/Department of Defense Clinical Practice Guidelines on the Management of
Bipolar Disorder in Adults (2010) - Attention Deficit Hyperactivity Disorder: What Are Pharmacists' Roles and Associated Outcomes? [Int J Environ Res Public Health 2023]
- The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG) [Eur Child Adolesc Psychiatry 2023]
- ADHD in adults with recurrent depression [J Affect Disord 2021]
- ADHD: Current Concepts and Treatments in Children and Adolescents [Neuropediatrics. 2020]
- Long-term medication for ADHD and development of cognitive functions in children and adolescents [J Psychiatr Res 2021]
- Parental ADHD in pregnancy and the postpartum period - A systematic review [Neurosci Biobehav Rev 2021]
- ADHD stimulant medication misuse and considerations for current prescribing practice: a literature review [Ir J Med Sci 2022]
- A literature review and meta-analysis on the effects of ADHD medications on functional outcomes [J Psychiatr Res 2020]
- Overdiagnosis of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Systematic Scoping Review [JAMA Netw Open 2021]
- ADHD Drugs in Pregnancy Not Linked to Children’s Brain Development [JAMA. 2023]
- American Academy of Pediatrics Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents (2019)
- American Academy of Family Physicians Diagnosis and Management of Attention-Deficit/Hyperactivity Disorder in Adults (2012)
- British Association for Psychopharmacology Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder (2014)
- National Institute for Health and Care Excellence Attention deficit hyperactivity disorder: diagnosis and management (2019)
- European Network Adult ADHD (ENAA) Updated European Consensus Statement on diagnosis and treatment of adult ADHD (2018)
- CPIC® Guideline for Atomoxetine based on CYP2D6 genotype (2016)
Updated September 2023